{"product_id":"selling-sickness-how-the-worlds-biggest-pharmaceutical-companies-are-turning-us-all-into-patients-paperback","title":"Selling Sickness: How the World's Biggest Pharmaceutical Companies Are Turning Us All Into Patients - Paperback","description":"\u003cdiv\u003e\u003cp style=\"text-align: right;\"\u003e\u003ca href=\"https:\/\/reportcopyrightinfringement.com\/\" target=\"_blank\" rel=\"nofollow\"\u003e\u003cb\u003eReport copyright infringement\u003c\/b\u003e\u003c\/a\u003e\u003c\/p\u003e\u003c\/div\u003e\u003cp\u003eby \u003cb\u003eRay Moynihan\u003c\/b\u003e (Author), \u003cb\u003eAlan Cassels\u003c\/b\u003e (Author)\u003c\/p\u003e\u003cp\u003eThirty years ago, Henry Gadsden, the head of Merck, one of the world's largest drug companies, told Fortune magazine that he wanted Merck to be more like chewing gum maker Wrigley's. It had long been his dream to make drugs for healthy people so that Merck could sell to everyone. Gadsden's dream now drives the marketing machinery of the most profitable industry on earth. Drug companies are systematically working to widen the very boundaries that define illness, and the markets for medication grow ever larger. Mild problems are redefined as serious illness and common complaints are labeled as medical conditions requiring drug treatments. Runny noses are now allergic rhinitis, PMS has become a psychiatric disorder, and hyperactive children have ADD. When it comes to conditions like high cholesterol or low bone density, being at risk is sold as a disease. Selling Sickness reveals how widening the boundaries of illness and lowering the threshold for treatments is creating millions of new patients and billions in new profits, in turn threatening to bankrupt health-care systems all over the world.As more and more of ordinary life becomes medicalized, the industry moves ever closer to Gadsden's dream: selling to everyone.\u003c\/p\u003e\u003ch3\u003eAuthor Biography\u003c\/h3\u003e\u003cp\u003e\u003cb\u003eRay Moynihan\u003c\/b\u003e is one of the world's leading health writers. His work has appeared in the \u003ci\u003eSydney Morning Herald\u003c\/i\u003e, the \u003ci\u003eAge\u003c\/i\u003e, the \u003ci\u003eAustralian Financial Review\u003c\/i\u003e, the \u003ci\u003eBritish Medical Journal, Lancet\u003c\/i\u003e, and \u003ci\u003eNew England Journal of Medicine\u003c\/i\u003e. \u003c\/p\u003e\u003cp\u003e\u003c\/p\u003e\u003cb\u003eAlan Cassels\u003c\/b\u003e is a Canadian researcher and writer who works on drug policy issues.\n            \u003cdiv\u003e\n\u003cstrong\u003eNumber of Pages:\u003c\/strong\u003e 272\u003c\/div\u003e\n            \u003cdiv\u003e\n\u003cstrong\u003eDimensions:\u003c\/strong\u003e 0.73 x 8.33 x 5.35 IN\u003c\/div\u003e\n            \u003cdiv\u003e\n\u003cstrong\u003ePublication Date:\u003c\/strong\u003e June 23, 2006\u003c\/div\u003e\n            ","brand":"Books by splitShops","offers":[{"title":"Default Title","offer_id":43423993069635,"sku":"9781560258568","price":21.99,"currency_code":"USD","in_stock":true}],"url":"https:\/\/store7994.com\/products\/selling-sickness-how-the-worlds-biggest-pharmaceutical-companies-are-turning-us-all-into-patients-paperback","provider":"STORE 7994","version":"1.0","type":"link"}